A study of increased levels of soluble vascular cell adhesion molecule-1 (sVCAM-1) in the cerebrospinal fluid of patients with multiple sclerosis and systemic lupus erythematosus

被引:11
|
作者
Baraczka, K
Pozsonyi, T
Szongoth, M
Nékám, K
Megyeri, A
Balogh, Z
Jakab, L
机构
[1] Natl Inst Rheumatol & Physiotherapy, Budapest, Hungary
[2] Dept Neurol, Budapest, Hungary
[3] Semmelweis Med Sch, Clin Internal Med 3, Budapest, Hungary
来源
ACTA NEUROLOGICA SCANDINAVICA | 1999年 / 99卷 / 02期
关键词
multiple sclerosis; systemic lupus erythematosus; cerebrospinal fluid; soluble vascular cell adhesion molecules;
D O I
10.1111/j.1600-0404.1999.tb00664.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The concentration of soluble vascular cell adhesion molecules (sVCAM-1) of serum and cerebrospinal fluid (CSF) was measured in clinically selected multiple sclerosis (MS) and systemic lupus erythematosus (SLE) patients, using an ELISA assay. The mean sVCAM-1 concentration in the serum of SLE patients was higher than normal. The mean CSF sVCAM-1 concentration was increased in the MS as in the SLE group. On analysis, the data suggests that there are some similarities in the immunological effects of these two different diseases of the central nervous system. A longitudinal analysis of the CSF is requested.
引用
收藏
页码:95 / 99
页数:5
相关论文
共 50 条
  • [21] Soluble Intercellular Adhesion Molecule-1 in children with Systemic Lupus Erythematosus
    Alyasins, S.
    Amin, R.
    ALLERGY, 2009, 64 : 257 - 257
  • [22] Serum soluble vascular cell adhesion molecule-1 (sVCAM-1) in scleroderma patients and its relation to pulmonary involvement and disease activity
    Alzawawy, A. I.
    Suliman, I.
    Hamimi, A.
    Elsawy, N.
    Albordiny, M. M.
    EGYPTIAN RHEUMATOLOGIST, 2011, 33 (01): : 21 - 26
  • [23] Soluble intercellular adhesion molecule-1 (sICAM-1) in patients with systemic lupus erythematosus
    Tulek, N
    Aydintug, O
    Ozoran, K
    Tutkak, H
    Duzgun, N
    Duman, M
    Tokgoz, G
    CLINICAL RHEUMATOLOGY, 1996, 15 (01) : 47 - 50
  • [24] INCREASED LEVELS OF INTERCELLULAR-ADHESION MOLECULE-1 IN THE SERUM OF PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    SFIKAKIS, PP
    CHARALAMBOPOULOS, D
    VAYIOPOULOS, G
    OGLESBY, R
    SFIKAKIS, P
    TSOKOS, GC
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1994, 12 (01) : 5 - 9
  • [25] Elevated plasma concentrations of nitric oxide, soluble thrombomodulin and soluble vascular cell adhesion molecule-1 in patients with systemic lupus erythematosus
    Ho, CY
    Wong, CK
    Li, EK
    Tam, LS
    Lam, CWK
    RHEUMATOLOGY, 2003, 42 (01) : 117 - 122
  • [26] Serum levels of soluble vascular cell adhesion molecule-1 (sVCAM-1) are elevated in advanced stages of non-Hodgkin's lymphomas
    Christiansen, I
    Sundström, C
    Kälkner, KM
    Bring, J
    Tötterman, TH
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1998, 61 (05) : 311 - 318
  • [27] Mycophenolate mofetil and azathioprine reduce soluble Vascular Cell Adhesion Molecule-1 (VCAM-1) and soluble Intercellular Adhesion Molecule-1 (ICAM-1) in systemic lupus erythematosus
    Lewis, M. J.
    Murru, V.
    Khamashta, M. A.
    Hughes, G. R. V.
    D'Cruz, D. P.
    RHEUMATOLOGY, 2006, 45 : I16 - I16
  • [28] Levels of soluble vascular cell adhesion molecule-1 and soluble intercellular adhesion molecule-1 are increased in women with ovarian hyperstimulation syndrome
    Daniel, Y
    Geva, E
    Amit, A
    Baram, A
    Englander, T
    Kupferminc, MJ
    Fait, G
    Lessing, JB
    FERTILITY AND STERILITY, 1999, 71 (05) : 896 - 901
  • [29] Soluble adhesion molecules (sVCAM-1 and sICAM-1) in cerebrospinal fluid and serum correlate with MRI activity in multiple sclerosis
    Rieckmann, P
    Altenhofen, B
    Riegel, A
    Baudewig, J
    Felgenhauer, K
    ANNALS OF NEUROLOGY, 1997, 41 (03) : 326 - 333
  • [30] Time course of the soluble vascular cell adhesion molecule-1 (sVCAM-1) expression in the streptozotosion-induced diabetic rats
    Kinukawa, Y
    Shimura, M
    Tomita, H
    Tamai, M
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S680 - S680